Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Physiological bile acid and bilirubin homeostasis refers to the integrated regulatory network responsible for the synthesis, transport, and excretion of bile salts and heme degradation products [Physiological Reviews, 2003]. This system is not a single molecular target but a coordinated pathway involving nuclear receptors like the Farnesoid X Receptor (FXR), enzymes such as UDP-glucuronosyltransferase 1A1 (UGT1A1), and various hepatic transporters including OATP1B1 and BSEP [Hepatology, 2009; Pharmacological Reviews, 2010]. Bile acids are essential for the emulsification of dietary lipids and act as signaling molecules that regulate systemic metabolism [Genes & Development, 2008]. Bilirubin, a byproduct of heme catabolism, requires efficient conjugation by UGT1A1 and transport by MRP2 to prevent toxic accumulation [StatPearls, 2023]. Dysregulation of these processes leads to pathological conditions such as cholestasis, jaundice, and primary biliary cholangitis [The Lancet, 2018]. Pharmacological interventions typically target specific components of this network, such as using FXR agonists like obeticholic acid to reduce bile acid synthesis or enzyme inducers to enhance bilirubin clearance [NEJM, 2016].
Regulation of bile acid and bilirubin levels through the activation of nuclear receptors (e.g., FXR), induction of conjugating enzymes (e.g., UGT1A1), and modulation of hepatic transporters (e.g., OATPs, BSEP, MRP2) [Physiological Reviews, 2003; StatPearls, 2023].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological bile acid and bilirubin homeostasis.